SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026302
Filing Date
2021-05-11
Accepted
2021-05-11 08:10:58
Documents
70
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ubx-10q_20210331.htm   iXBRL 10-Q 2691609
2 EX-10.1 ubx-ex101_59.htm EX-10.1 111835
3 EX-31.1 ubx-ex311_8.htm EX-31.1 21316
4 EX-31.2 ubx-ex312_6.htm EX-31.2 21234
5 EX-32.1 ubx-ex321_7.htm EX-32.1 14566
  Complete submission text file 0001564590-21-026302.txt   9568578

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ubx-20210331.xsd EX-101.SCH 62437
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ubx-20210331_cal.xml EX-101.CAL 51551
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ubx-20210331_def.xml EX-101.DEF 187535
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20210331_lab.xml EX-101.LAB 460883
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20210331_pre.xml EX-101.PRE 352130
11 EXTRACTED XBRL INSTANCE DOCUMENT ubx-10q_20210331_htm.xml XML 1864517
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38470 | Film No.: 21909704
SIC: 2834 Pharmaceutical Preparations